CR1 and thalassemia: It is not clear how α+-thalassaemia might prevent progression to SMA; however, recent observations by Cockburn and colleagues [46] regarding the expression of complement receptor 1 (CR1) on the surface of α+-thalassaemic red blood cells might prove relevant.